The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kim Hanna, MSc
Grifols Therapeutics LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Cambridge - Cambridge Institute for Medical Research
Cambridge, England, United Kingdom
- University Teaching Hospital of Edinburgh
Edinburgh, Scotland, United Kingdom
- National Jewish Medical and Research Center
Denver, Colorado, United States
- University of Florida College of Medicine
Gainesville, Florida, United States
- University of Miami School of Medicine
Miami, Florida, United States
- St Lukes-Roosevelt Hospital Center, New York
New York, New York, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Temple University Hospital
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Texas Health Center at Tyler
Tyler, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2006
- Primary completion
- 31 Mar 2007
- Completion
- 31 Mar 2007
- Last update posted
- 19 Aug 2014
- Registered enrollment
- 38
- Registry id
- NCT00301366
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.